Brief: In8bio's Deltex Gamma-Delta T Cells Show Promise In Targeting Ovarian Cancer
IN8BIO, Inc. INAB.O :
* IN8BIO'S DELTEX GAMMA-DELTA T CELLS SHOW PROMISE IN
TARGETING
OVARIAN CANCER
Source text for Eikon: ID:nGNX4J0Mtv
Further company coverage: INAB.O
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall